|
Volumn 31, Issue 2, 2008, Pages 181-
|
Statins, regulatory T cells and amyotrophic lateral sclerosis [1]
a b c |
Author keywords
Amyotrophic lateral sclerosis; HMG CoA reductase inhibitors, adverse reactions; HMG CoA reductase inhibitors, therapeutic use; Motor neuron disorders; Pharmacovigilance
|
Indexed keywords
GLUTAMIC ACID;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TRANSCRIPTION FACTOR FOXP3;
AMYOTROPHIC LATERAL SCLEROSIS;
ATHEROMA;
ATHEROSCLEROTIC PLAQUE;
AUTOIMMUNITY;
CD4+ CD25+ T LYMPHOCYTE;
CELL PROTECTION;
DEGENERATIVE DISEASE;
DOWN REGULATION;
EXCITOTOXICITY;
HELPER CELL;
HUMAN;
IMMUNITY;
IN VIVO STUDY;
INCIDENCE;
LETTER;
NEUROPROTECTION;
PHYSICIAN;
PLEIOTROPY;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
SIDE EFFECT;
T LYMPHOCYTE;
|
EID: 38549113445
PISSN: 01145916
EISSN: None
Source Type: Journal
DOI: 10.2165/00002018-200831020-00007 Document Type: Letter |
Times cited : (1)
|
References (8)
|